GlaxoSmithKline has been using testing, calibrating and advising company Exova since 2009, and a contract renewal will see the firms work together for at least another three years across eight of the Big Pharma’s production sites in the UK and Ireland.
Exova will continue to provide GSK with health and safety and environmental performance services, working both from the manufacturing sites and at its environmental laboratories.
Alastair Wolff, sector director of Infrastructure & Environment at Exova, said his firm was “delighted to continue this partnership,” adding the renewal of the contract until 2019 is “testament to the strong relationships we build with our customers and the quality of our technically demanding testing services.”
GSK’s environmental health and safety manager Dave Postle added: “We have developed a strong relationship with Exova who have delivered an effective, competent and compliant service for GSK over a number of years in these specialised areas.
“We look forward to continuing and developing this over the next three years.”
GSK’s UK and Ireland network includes sites in Ware, Hertfordshire, Barnard Castle, County Durham, and Montrose, Scotland which are all part of a £275m ($331m) expansion project announced by the company last July.